Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ulcerative Colitis, Active Moderate”

261 trials

Showing 20 of 261 results

Testing effectiveness (Phase 2)Study completedNCT00729872
What this trial is testing

A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis

Who this might be right for
Moderately Active Ulcerative Colitis
ActoGeniX N.V. 60
Testing effectiveness (Phase 2)Ended earlyNCT04987307
What this trial is testing

Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Amgen 221
Not applicableLooking for participantsNCT06764706
What this trial is testing

Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 200
Testing effectiveness (Phase 2)Looking for participantsNCT07083193
What this trial is testing

AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Accro Bioscience (Suzhou) Limited 24
Post-approval studies (Phase 4)Looking for participantsNCT04314375
What this trial is testing

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bausch Health Americas, Inc. 70
Testing effectiveness (Phase 2)Looking for participantsNCT06764615
What this trial is testing

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Who this might be right for
Crohn's DiseaseUlcerative Colitis
Takeda 183
Not applicableStudy completedNCT00951548
What this trial is testing

Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
VSL Pharmaceuticals 144
Testing effectiveness (Phase 2)Study completedNCT02493712
What this trial is testing

A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M

Who this might be right for
Colitis, Ulcerative
Holy Stone Healthcare Co., Ltd 51
Testing effectiveness (Phase 2)Study completedNCT05570006
What this trial is testing

Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 30
Large-scale testing (Phase 3)Study completedNCT01008410
What this trial is testing

Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

Who this might be right for
ProctitisProctosigmoiditis
Bausch Health Americas, Inc. 265
Testing effectiveness (Phase 2)Ended earlyNCT01706159
What this trial is testing

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Who this might be right for
InflammationUlcerative Colitis
Novo Nordisk A/S 20
Testing effectiveness (Phase 2)Study completedNCT04996797
What this trial is testing

Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

Who this might be right for
Ulcerative Colitis
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 178
Large-scale testing (Phase 3)Study completedNCT00488631
What this trial is testing

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 1,228
Large-scale testing (Phase 3)Study completedNCT02165215
What this trial is testing

The Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Colitis, Ulcerative
Hoffmann-La Roche 359
Testing effectiveness (Phase 2)Looking for participantsNCT07035041
What this trial is testing

D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
UC - Ulcerative ColitisModerately to Severely Active Ulcerative Colitis
InventisBio Co., Ltd 120
Testing effectiveness (Phase 2)Study completedNCT01988961
What this trial is testing

Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 103
Testing effectiveness (Phase 2)Study completedNCT03093259
What this trial is testing

ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abivax S.A. 32
Testing effectiveness (Phase 2)Looking for participantsNCT05287126
What this trial is testing

Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer 36
Post-approval studies (Phase 4)Not Yet RecruitingNCT05976802
What this trial is testing

Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bausch Health Americas, Inc. 100
Large-scale testing (Phase 3)Study completedNCT02065622
What this trial is testing

Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
AbbVie 952
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation